These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26503259)

  • 1. Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.
    Modi S; Kir D; Giri B; Majumder K; Arora N; Dudeja V; Banerjee S; Saluja AK
    J Gastrointest Surg; 2016 Jan; 20(1):13-23; discussion 23-4. PubMed ID: 26503259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
    Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
    FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
    Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
    PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
    Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
    BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.
    Banerjee S; Modi S; McGinn O; Zhao X; Dudeja V; Ramakrishnan S; Saluja AK
    Clin Cancer Res; 2016 Jan; 22(2):415-25. PubMed ID: 26405195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
    Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
    Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
    Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
    Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
    Chugh R; Sangwan V; Patil SP; Dudeja V; Dawra RK; Banerjee S; Schumacher RJ; Blazar BR; Georg GI; Vickers SM; Saluja AK
    Sci Transl Med; 2012 Oct; 4(156):156ra139. PubMed ID: 23076356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
    Giri B; Gupta VK; Yaffe B; Modi S; Roy P; Sethi V; Lavania SP; Vickers SM; Dudeja V; Banerjee S; Watts J; Saluja A
    J Transl Med; 2019 May; 17(1):163. PubMed ID: 31109340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer.
    Modi S; Giri B; Gupta VK; Lavania S; Sethi V; Sharma NS; Pandey S; Vickers S; Dudeja V; Saluja AK
    Cancer Lett; 2022 Jul; 537():215591. PubMed ID: 35398530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide and Its Derivatives as Cancer Therapies.
    Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H
    Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
    Liu Y; Xiao E; Yuan L; Li G
    DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.
    Rivard C; Geller M; Schnettler E; Saluja M; Vogel RI; Saluja A; Ramakrishnan S
    Gynecol Oncol; 2014 Nov; 135(2):318-24. PubMed ID: 25172764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
    Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
    Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.
    Sangwan V; Banerjee S; Jensen KM; Chen Z; Chugh R; Dudeja V; Vickers SM; Saluja AK
    Pancreas; 2015 May; 44(4):583-9. PubMed ID: 25875797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
    Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
    J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minnelide, a novel drug for pancreatic and liver cancer.
    Banerjee S; Saluja A
    Pancreatology; 2015 Jul; 15(4 Suppl):S39-43. PubMed ID: 26122306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minnelide reduces tumor burden in preclinical models of osteosarcoma.
    Banerjee S; Thayanithy V; Sangwan V; Mackenzie TN; Saluja AK; Subramanian S
    Cancer Lett; 2013 Jul; 335(2):412-20. PubMed ID: 23499892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.
    Banerjee S; Nomura A; Sangwan V; Chugh R; Dudeja V; Vickers SM; Saluja A
    Clin Cancer Res; 2014 May; 20(9):2388-99. PubMed ID: 24634377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.
    Rousalova I; Banerjee S; Sangwan V; Evenson K; McCauley JA; Kratzke R; Vickers SM; Saluja A; D'Cunha J
    PLoS One; 2013; 8(10):e77411. PubMed ID: 24143232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.